Brief: Talis Provides Update On Regulatory Pathway For Emergency Use Authorization (EUA) Of Its Talis One Covid-19 Test

Talis Biomedical

08/03/2021 13:14

March 8 (Reuters) - Talis Biomedical Corp  TLIS.O :
    * TALIS PROVIDES UPDATE ON REGULATORY PATHWAY FOR EMERGENCY
USE
AUTHORIZATION (EUA) OF ITS TALIS ONE™ COVID-19 TEST
    * TALIS BIOMEDICAL CORP - WITHDRAWN CURRENT APPLICATION
PURSUING
U.S. FDA EUA FOR TALIS ONE COVID-19 TEST IN CLIA MODERATE
SETTING
    * TALIS BIOMEDICAL CORP - FOCUSING ON ITS PLANNED EUA
APPLICATION
IN CLIA WAIVED SETTING OF TALIS ONE COVID-19 TEST
    * TALIS BIOMEDICAL CORP - PLANS TO SUBMIT AN EUA APPLICATION
FOR
TALIS ONE COVID-19 TEST IN CLIA WAIVED SETTINGS EARLY IN Q2 OF
2021

Source text for Eikon:  ID:nGNX1QbcqR 
Further company coverage:  TLIS.O 

 ((Reuters.Briefs@thomsonreuters.com;))